Insulin resistance and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH)
Furkejuvvon:
| Váldodahkki: | |
|---|---|
| Searvvušdahkki: | |
| Materiálatiipa: | Elektrovnnalaš E-girji |
| Giella: | eaŋgalasgiella |
| Almmustuhtton: |
New York :
Nova Biomedical Books,
c2010.
|
| Ráidu: | Metabolic diseases--laboratory and clinical research series.
Novinka (Series) |
| Fáttát: | |
| Liŋkkat: | An electronic book accessible through the World Wide Web; click to view |
| Fáddágilkorat: |
Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
Sisdoallologahallan:
- NAFLD and insulin resistance (IR)
- Pathophysiology of NASH : insulin resistance, free fatty acids, and cytokines
- Adiponectin and NASH
- TNF-[alpha] and NAFLD/NASH
- Leptin and NAFLD/NASH
- Peroxisome proliferators-activated receptors (PPARs) and NAFLD/NASH
- Iron overload and NAFLD/NASH
- Mitochondrial abnormalities and NAFLD/NASH
- Genetic influences in NAFLD/NASH
- Therapeutic strategy for NASH patients
- Natural history of NAFLD
- Conclusions.